From: Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)
Gene variants | Predicted effect (snpEFF, ClinVar, snpNexus and PubMed) | Zygosity | Predicted impact | Reported inheritance patterns | Reference (first reported) |
---|---|---|---|---|---|
C1S (rs117907409) | Deleterious | Heterozygous | Disease-causing | AD | [76] |
SAMHD1 (c.811C>A) | Impacts catalytic activity | Heterozygous | Disease-causing or -modifier | AD/AR | [77] |
C3 (rs117793540) | Gain-of-function | Heterozygous | Disease-causing | AD/AR | |
TREX1 (rs1331920811) | Loss-of-function | Heterozygous | Disease-causing or -modifier | AD/AR | [80] |
SAMHD1 (c.811C>A) | Impacts catalytic activity | Heterozygous | Disease-causing or -modifier | AD | [77] |
IRF7 (c.-283-1G>T) | Loss-of-function | Heterozygous | Disease-modifier | AR | — |
C3 (c.4341C>A) | Loss-of-function | Heterozygous | Disease-causing or -modifier | AD/AR | — |
RNASEH2B (c.184G>T) | Deleterious | Heterozygous | Disease-modifier | AR | — |
BANK1 (rs928173624) | Loss-of-function | Heterozygous | Disease-causing or -modifier | N/A | |
PTPN22 (c.369+1G>T) | In silico predicted ‘high impact’ | Heterozygous | Disease-causing | AD | — |
TNFAIP3 (rs776714084) | Loss-of-function | Heterozygous | Disease-causing | AD | — |
RNASEH2A (rs549586181) | Loss-of-function | Heterozygous | Disease-modifier | AR | [80] |
C3 (c.1303G>T) | Loss-of-function | Heterozygous | Disease-modifier | AD/AR | — |
TNFSF4 (c.368_369delAG) | Loss-of-function | Heterozygous | Disease-modifier | N/A | — |
RNASEH2C (rs759118175) | Loss-of-function | Heterozygous | Disease-modifier | AR | — |
TREX1 (rs749323787) | Impacts catalytic activity | Heterozygous | Disease-causing | AD/AR | [82] |
SAMHD1 (rs1400380009) | Loss-of-function | Heterozygous | Disease-causing | AD/AR | — |
PEPD (rs529315200) | Loss-of-function | Heterozygous | Disease-modifier | AR | [83] |
DNASE1 (rs201571412) | Loss-of-function | Heterozygous | Disease causing | AD | [84] |